nodes	percent_of_prediction	percent_of_DWPC	metapath
Alverine—HTR1A—Parkinson's disease	0.97	1	CbGaD
Alverine—HTR1A—telencephalic ventricle—Parkinson's disease	0.00403	0.309	CbGeAlD
Alverine—HTR1A—hindbrain—Parkinson's disease	0.0019	0.146	CbGeAlD
Alverine—HTR1A—brainstem—Parkinson's disease	0.00109	0.0836	CbGeAlD
Alverine—HTR1A—forebrain—Parkinson's disease	0.00105	0.0807	CbGeAlD
Alverine—Benzphetamine—SLC18A2—Parkinson's disease	0.000951	0.178	CrCbGaD
Alverine—HTR1A—cardiovascular system—Parkinson's disease	0.000891	0.0682	CbGeAlD
Alverine—HTR1A—Serotonin receptors—HTR7—Parkinson's disease	0.000863	0.0727	CbGpPWpGaD
Alverine—HTR1A—midbrain—Parkinson's disease	0.000695	0.0533	CbGeAlD
Alverine—HTR1A—spinal cord—Parkinson's disease	0.000679	0.052	CbGeAlD
Alverine—HTR1A—Serotonin receptors—HTR2A—Parkinson's disease	0.000604	0.0509	CbGpPWpGaD
Alverine—HTR1A—head—Parkinson's disease	0.000603	0.0462	CbGeAlD
Alverine—HTR1A—nervous system—Parkinson's disease	0.000572	0.0438	CbGeAlD
Alverine—HTR1A—central nervous system—Parkinson's disease	0.00055	0.0422	CbGeAlD
Alverine—HTR1A—cerebellum—Parkinson's disease	0.000538	0.0412	CbGeAlD
Alverine—Clomifene—CYP2E1—Parkinson's disease	0.000477	0.0892	CrCbGaD
Alverine—Modafinil—SLC6A3—Parkinson's disease	0.000455	0.0851	CrCbGaD
Alverine—HTR1A—Monoamine GPCRs—DRD1—Parkinson's disease	0.000439	0.037	CbGpPWpGaD
Alverine—HTR1A—brain—Parkinson's disease	0.000437	0.0335	CbGeAlD
Alverine—HTR1A—SIDS Susceptibility Pathways—EN1—Parkinson's disease	0.000428	0.0361	CbGpPWpGaD
Alverine—HTR1A—Monoamine GPCRs—DRD3—Parkinson's disease	0.000425	0.0358	CbGpPWpGaD
Alverine—Tripelennamine—CYP2D6—Parkinson's disease	0.000421	0.0788	CrCbGaD
Alverine—Aprindine—CYP2D6—Parkinson's disease	0.000411	0.077	CrCbGaD
Alverine—Benzphetamine—SLC6A3—Parkinson's disease	0.000394	0.0738	CrCbGaD
Alverine—HTR1A—Monoamine GPCRs—DRD2—Parkinson's disease	0.000384	0.0324	CbGpPWpGaD
Alverine—HTR1A—Monoamine GPCRs—HTR7—Parkinson's disease	0.000384	0.0324	CbGpPWpGaD
Alverine—HTR1A—Amine ligand-binding receptors—DRD1—Parkinson's disease	0.000369	0.0311	CbGpPWpGaD
Alverine—HTR1A—Amine ligand-binding receptors—DRD3—Parkinson's disease	0.000357	0.0301	CbGpPWpGaD
Alverine—HTR1A—SIDS Susceptibility Pathways—ATP1A3—Parkinson's disease	0.000324	0.0273	CbGpPWpGaD
Alverine—HTR1A—Amine ligand-binding receptors—HTR7—Parkinson's disease	0.000323	0.0272	CbGpPWpGaD
Alverine—HTR1A—Amine ligand-binding receptors—DRD2—Parkinson's disease	0.000323	0.0272	CbGpPWpGaD
Alverine—Propafenone—CYP2D6—Parkinson's disease	0.000285	0.0534	CrCbGaD
Alverine—HTR1A—Monoamine GPCRs—HTR2A—Parkinson's disease	0.000269	0.0227	CbGpPWpGaD
Alverine—Bepridil—CYP2D6—Parkinson's disease	0.000254	0.0476	CrCbGaD
Alverine—Clomifene—ABCB1—Parkinson's disease	0.00025	0.0468	CrCbGaD
Alverine—Dextropropoxyphene—CYP2D6—Parkinson's disease	0.000236	0.0442	CrCbGaD
Alverine—HTR1A—Amine ligand-binding receptors—HTR2A—Parkinson's disease	0.000226	0.0191	CbGpPWpGaD
Alverine—HTR1A—GPCRs, Class A Rhodopsin-like—GPR37—Parkinson's disease	0.000217	0.0183	CbGpPWpGaD
Alverine—Orphenadrine—CYP2E1—Parkinson's disease	0.000214	0.04	CrCbGaD
Alverine—Propafenone—ABCB1—Parkinson's disease	0.000204	0.0381	CrCbGaD
Alverine—HTR1A—SIDS Susceptibility Pathways—DDC—Parkinson's disease	0.000202	0.0171	CbGpPWpGaD
Alverine—HTR1A—Class A/1 (Rhodopsin-like receptors)—GPR37—Parkinson's disease	0.000186	0.0157	CbGpPWpGaD
Alverine—Bepridil—ABCB1—Parkinson's disease	0.000182	0.034	CrCbGaD
Alverine—Fentanyl—ABCB1—Parkinson's disease	0.000167	0.0312	CrCbGaD
Alverine—Diphenhydramine—CYP2D6—Parkinson's disease	0.000166	0.0311	CrCbGaD
Alverine—Methadone—CYP2D6—Parkinson's disease	0.00016	0.03	CrCbGaD
Alverine—HTR1A—G alpha (i) signalling events—GRM4—Parkinson's disease	0.000159	0.0134	CbGpPWpGaD
Alverine—HTR1A—G alpha (i) signalling events—PENK—Parkinson's disease	0.000151	0.0127	CbGpPWpGaD
Alverine—HTR1A—GPCR ligand binding—GPR37—Parkinson's disease	0.000141	0.0119	CbGpPWpGaD
Alverine—HTR1A—G alpha (i) signalling events—PDYN—Parkinson's disease	0.000138	0.0116	CbGpPWpGaD
Alverine—HTR1A—SIDS Susceptibility Pathways—CHRNA4—Parkinson's disease	0.000136	0.0115	CbGpPWpGaD
Alverine—HTR1A—SIDS Susceptibility Pathways—TAC1—Parkinson's disease	0.000129	0.0109	CbGpPWpGaD
Alverine—HTR1A—Class A/1 (Rhodopsin-like receptors)—PENK—Parkinson's disease	0.00012	0.0101	CbGpPWpGaD
Alverine—Methadone—ABCB1—Parkinson's disease	0.000114	0.0214	CrCbGaD
Alverine—HTR1A—SIDS Susceptibility Pathways—TH—Parkinson's disease	0.000113	0.00951	CbGpPWpGaD
Alverine—HTR1A—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.000109	0.00923	CbGpPWpGaD
Alverine—HTR1A—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	0.000101	0.00851	CbGpPWpGaD
Alverine—HTR1A—GPCR ligand binding—GRM4—Parkinson's disease	9.61e-05	0.0081	CbGpPWpGaD
Alverine—HTR1A—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	9.53e-05	0.00803	CbGpPWpGaD
Alverine—HTR1A—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	9.19e-05	0.00775	CbGpPWpGaD
Alverine—HTR1A—GPCR ligand binding—PENK—Parkinson's disease	9.11e-05	0.00768	CbGpPWpGaD
Alverine—HTR1A—G alpha (i) signalling events—DRD3—Parkinson's disease	8.83e-05	0.00745	CbGpPWpGaD
Alverine—HTR1A—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	8.65e-05	0.00729	CbGpPWpGaD
Alverine—HTR1A—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	8.46e-05	0.00713	CbGpPWpGaD
Alverine—HTR1A—GPCR ligand binding—PDYN—Parkinson's disease	8.34e-05	0.00703	CbGpPWpGaD
Alverine—HTR1A—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	8.2e-05	0.00691	CbGpPWpGaD
Alverine—HTR1A—SIDS Susceptibility Pathways—NGF—Parkinson's disease	8.16e-05	0.00688	CbGpPWpGaD
Alverine—HTR1A—GPCR downstream signaling—DGKQ—Parkinson's disease	7.99e-05	0.00674	CbGpPWpGaD
Alverine—HTR1A—G alpha (i) signalling events—DRD2—Parkinson's disease	7.99e-05	0.00673	CbGpPWpGaD
Alverine—HTR1A—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	7.76e-05	0.00655	CbGpPWpGaD
Alverine—HTR1A—GPCR ligand binding—GRM5—Parkinson's disease	7.75e-05	0.00653	CbGpPWpGaD
Alverine—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	7.41e-05	0.00625	CbGpPWpGaD
Alverine—HTR1A—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	7.41e-05	0.00625	CbGpPWpGaD
Alverine—HTR1A—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	7.39e-05	0.00623	CbGpPWpGaD
Alverine—HTR1A—Signaling by GPCR—DGKQ—Parkinson's disease	7.26e-05	0.00612	CbGpPWpGaD
Alverine—HTR1A—Signaling by GPCR—GPR37—Parkinson's disease	7.26e-05	0.00612	CbGpPWpGaD
Alverine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	7.25e-05	0.00611	CbGpPWpGaD
Alverine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	7.02e-05	0.00592	CbGpPWpGaD
Alverine—HTR1A—Signaling by GPCR—PPP1R1B—Parkinson's disease	6.64e-05	0.0056	CbGpPWpGaD
Alverine—HTR1A—GPCR ligand binding—ADORA2A—Parkinson's disease	6.59e-05	0.00555	CbGpPWpGaD
Alverine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	6.35e-05	0.00535	CbGpPWpGaD
Alverine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	6.35e-05	0.00535	CbGpPWpGaD
Alverine—HTR1A—GPCR downstream signaling—GRK5—Parkinson's disease	6.06e-05	0.00511	CbGpPWpGaD
Alverine—HTR1A—GPCR ligand binding—TAC1—Parkinson's disease	5.63e-05	0.00475	CbGpPWpGaD
Alverine—HTR1A—GPCR ligand binding—DRD1—Parkinson's disease	5.52e-05	0.00465	CbGpPWpGaD
Alverine—HTR1A—Signaling by GPCR—GRK5—Parkinson's disease	5.5e-05	0.00464	CbGpPWpGaD
Alverine—HTR1A—GPCR downstream signaling—GRM4—Parkinson's disease	5.43e-05	0.00458	CbGpPWpGaD
Alverine—HTR1A—GPCR ligand binding—DRD3—Parkinson's disease	5.35e-05	0.00451	CbGpPWpGaD
Alverine—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	5.19e-05	0.00438	CbGpPWpGaD
Alverine—HTR1A—Signaling Pathways—VPS35—Parkinson's disease	5.17e-05	0.00436	CbGpPWpGaD
Alverine—HTR1A—GPCR downstream signaling—PENK—Parkinson's disease	5.15e-05	0.00434	CbGpPWpGaD
Alverine—HTR1A—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	5.08e-05	0.00429	CbGpPWpGaD
Alverine—HTR1A—Signaling by GPCR—GRM4—Parkinson's disease	4.93e-05	0.00416	CbGpPWpGaD
Alverine—HTR1A—GPCR ligand binding—DRD2—Parkinson's disease	4.84e-05	0.00408	CbGpPWpGaD
Alverine—HTR1A—GPCR ligand binding—HTR7—Parkinson's disease	4.84e-05	0.00408	CbGpPWpGaD
Alverine—HTR1A—GPCR downstream signaling—PDYN—Parkinson's disease	4.71e-05	0.00397	CbGpPWpGaD
Alverine—HTR1A—Signaling by GPCR—PENK—Parkinson's disease	4.68e-05	0.00394	CbGpPWpGaD
Alverine—HTR1A—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	4.6e-05	0.00388	CbGpPWpGaD
Alverine—HTR1A—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	4.59e-05	0.00387	CbGpPWpGaD
Alverine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	4.45e-05	0.00375	CbGpPWpGaD
Alverine—HTR1A—GPCR downstream signaling—GRM5—Parkinson's disease	4.38e-05	0.00369	CbGpPWpGaD
Alverine—HTR1A—Signaling Pathways—GPR37—Parkinson's disease	4.29e-05	0.00361	CbGpPWpGaD
Alverine—HTR1A—Signaling Pathways—DGKQ—Parkinson's disease	4.29e-05	0.00361	CbGpPWpGaD
Alverine—HTR1A—Signaling by GPCR—PDYN—Parkinson's disease	4.28e-05	0.00361	CbGpPWpGaD
Alverine—HTR1A—Signaling by GPCR—GRM5—Parkinson's disease	3.98e-05	0.00335	CbGpPWpGaD
Alverine—HTR1A—Signaling Pathways—PPP1R1B—Parkinson's disease	3.92e-05	0.00331	CbGpPWpGaD
Alverine—HTR1A—GPCR ligand binding—EDN1—Parkinson's disease	3.87e-05	0.00326	CbGpPWpGaD
Alverine—HTR1A—GPCR downstream signaling—ADORA2A—Parkinson's disease	3.72e-05	0.00314	CbGpPWpGaD
Alverine—HTR1A—Signaling Pathways—RIT2—Parkinson's disease	3.43e-05	0.00289	CbGpPWpGaD
Alverine—HTR1A—GPCR ligand binding—HTR2A—Parkinson's disease	3.39e-05	0.00286	CbGpPWpGaD
Alverine—HTR1A—Signaling by GPCR—ADORA2A—Parkinson's disease	3.38e-05	0.00285	CbGpPWpGaD
Alverine—HTR1A—SIDS Susceptibility Pathways—TNF—Parkinson's disease	3.34e-05	0.00281	CbGpPWpGaD
Alverine—HTR1A—Signaling Pathways—GRK5—Parkinson's disease	3.25e-05	0.00274	CbGpPWpGaD
Alverine—HTR1A—GPCR downstream signaling—TAC1—Parkinson's disease	3.18e-05	0.00268	CbGpPWpGaD
Alverine—HTR1A—GPCR downstream signaling—DRD1—Parkinson's disease	3.12e-05	0.00263	CbGpPWpGaD
Alverine—HTR1A—GPCR downstream signaling—DRD3—Parkinson's disease	3.02e-05	0.00255	CbGpPWpGaD
Alverine—HTR1A—Signaling Pathways—GRM4—Parkinson's disease	2.91e-05	0.00246	CbGpPWpGaD
Alverine—HTR1A—Signaling by GPCR—TAC1—Parkinson's disease	2.89e-05	0.00244	CbGpPWpGaD
Alverine—HTR1A—Signaling by GPCR—DRD1—Parkinson's disease	2.83e-05	0.00239	CbGpPWpGaD
Alverine—HTR1A—GPCR downstream signaling—ADRBK1—Parkinson's disease	2.82e-05	0.00238	CbGpPWpGaD
Alverine—HTR1A—Signaling Pathways—PENK—Parkinson's disease	2.76e-05	0.00233	CbGpPWpGaD
Alverine—HTR1A—Signaling Pathways—MAG—Parkinson's disease	2.76e-05	0.00233	CbGpPWpGaD
Alverine—HTR1A—Signaling by GPCR—DRD3—Parkinson's disease	2.74e-05	0.00231	CbGpPWpGaD
Alverine—HTR1A—GPCR downstream signaling—HTR7—Parkinson's disease	2.73e-05	0.0023	CbGpPWpGaD
Alverine—HTR1A—GPCR downstream signaling—DRD2—Parkinson's disease	2.73e-05	0.0023	CbGpPWpGaD
Alverine—HTR1A—SIDS Susceptibility Pathways—IL6—Parkinson's disease	2.69e-05	0.00227	CbGpPWpGaD
Alverine—HTR1A—Signaling by GPCR—ADRBK1—Parkinson's disease	2.56e-05	0.00216	CbGpPWpGaD
Alverine—HTR1A—Signaling Pathways—PDYN—Parkinson's disease	2.53e-05	0.00213	CbGpPWpGaD
Alverine—HTR1A—Signaling by GPCR—HTR7—Parkinson's disease	2.48e-05	0.00209	CbGpPWpGaD
Alverine—HTR1A—Signaling by GPCR—DRD2—Parkinson's disease	2.48e-05	0.00209	CbGpPWpGaD
Alverine—HTR1A—Signaling Pathways—GFAP—Parkinson's disease	2.38e-05	0.002	CbGpPWpGaD
Alverine—HTR1A—Signaling Pathways—GRM5—Parkinson's disease	2.35e-05	0.00198	CbGpPWpGaD
Alverine—HTR1A—GPCR downstream signaling—EDN1—Parkinson's disease	2.19e-05	0.00184	CbGpPWpGaD
Alverine—HTR1A—Signaling Pathways—FGF20—Parkinson's disease	2.06e-05	0.00174	CbGpPWpGaD
Alverine—HTR1A—Signaling Pathways—ADORA2A—Parkinson's disease	2e-05	0.00168	CbGpPWpGaD
Alverine—HTR1A—Signaling by GPCR—EDN1—Parkinson's disease	1.99e-05	0.00168	CbGpPWpGaD
Alverine—HTR1A—GPCR downstream signaling—HTR2A—Parkinson's disease	1.91e-05	0.00161	CbGpPWpGaD
Alverine—HTR1A—Signaling Pathways—INSR—Parkinson's disease	1.84e-05	0.00155	CbGpPWpGaD
Alverine—HTR1A—Signaling Pathways—FGB—Parkinson's disease	1.74e-05	0.00147	CbGpPWpGaD
Alverine—HTR1A—Signaling by GPCR—HTR2A—Parkinson's disease	1.74e-05	0.00147	CbGpPWpGaD
Alverine—HTR1A—Signaling Pathways—TAC1—Parkinson's disease	1.71e-05	0.00144	CbGpPWpGaD
Alverine—HTR1A—Signaling Pathways—DRD1—Parkinson's disease	1.67e-05	0.00141	CbGpPWpGaD
Alverine—HTR1A—Signaling Pathways—DRD3—Parkinson's disease	1.62e-05	0.00137	CbGpPWpGaD
Alverine—HTR1A—Signaling Pathways—ADRBK1—Parkinson's disease	1.51e-05	0.00128	CbGpPWpGaD
Alverine—HTR1A—Signaling Pathways—HTR7—Parkinson's disease	1.47e-05	0.00124	CbGpPWpGaD
Alverine—HTR1A—Signaling Pathways—DRD2—Parkinson's disease	1.47e-05	0.00124	CbGpPWpGaD
Alverine—HTR1A—Signaling Pathways—IGF2—Parkinson's disease	1.23e-05	0.00104	CbGpPWpGaD
Alverine—HTR1A—Signaling Pathways—IGF1R—Parkinson's disease	1.19e-05	0.001	CbGpPWpGaD
Alverine—HTR1A—Signaling Pathways—EDN1—Parkinson's disease	1.17e-05	0.00099	CbGpPWpGaD
Alverine—HTR1A—Signaling Pathways—NGF—Parkinson's disease	1.08e-05	0.000909	CbGpPWpGaD
Alverine—HTR1A—Signaling Pathways—HTR2A—Parkinson's disease	1.03e-05	0.000866	CbGpPWpGaD
Alverine—HTR1A—Signaling Pathways—APOE—Parkinson's disease	9.55e-06	0.000805	CbGpPWpGaD
Alverine—HTR1A—Signaling Pathways—INS—Parkinson's disease	8.16e-06	0.000688	CbGpPWpGaD
Alverine—HTR1A—Signaling Pathways—CASP3—Parkinson's disease	6.07e-06	0.000512	CbGpPWpGaD
Alverine—HTR1A—Signaling by GPCR—IL6—Parkinson's disease	6.03e-06	0.000509	CbGpPWpGaD
Alverine—HTR1A—Signaling Pathways—MAPK8—Parkinson's disease	5.58e-06	0.00047	CbGpPWpGaD
Alverine—HTR1A—Signaling Pathways—IL6—Parkinson's disease	3.56e-06	0.0003	CbGpPWpGaD
